Somaxon Pharmaceuticals, Inc. President and Chief Executive Officer to Ring the NASDAQ Stock Market Opening Bell

Dec. 2, 2010 (GLOBE NEWSWIRE) -- Somaxon Pharmaceuticals, Inc. (SOMX), a specialty pharmaceutical company, will visit the NASDAQ MarketSite in New York City’s Times Square to celebrate the introduction of the company’s first commercial product, Silenor® (doxepin), which Somaxon launched in September 2010 with its co-promotion partner Procter & Gamble.